CANTEL MEDICAL CORP. (NYSE:CMD) Files An 8-K Financial Statements and Exhibits
Item 9.01 Financial Statements, Pro-Forma Financial Information and Exhibits
CANTEL MEDICAL CORP. (NYSE:CMD) Files An 8-K Financial Statements and Exhibits
(d) Exhibit 99.1 Press release of Registrant dated June 4, 2019.
CANTEL MEDICAL CORP Exhibit
EX-99.1 2 cantelfy19q3ex991.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Cantel Medical Reports Financial Results for its Third Quarter Fiscal Year 2019 Strong double digit growth in Medical,…
To view the full exhibit click
EX-99.1 2 cantelfy19q3ex991.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Cantel Medical Reports Financial Results for its Third Quarter Fiscal Year 2019 Strong double digit growth in Medical,…
To view the full exhibit click
hereAbout CANTEL MEDICAL CORP. (NYSE:CMD)
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies. The Company’s Water Purification and Filtration segment includes water purification equipment and services, filtration and separation products, and disinfectant, sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use, infection prevention and control healthcare products. The Company’s Dialysis segment includes medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis. The Company offers a range of filters utilizing hollow fiber membrane technology.
